Atovaquone (Alternative Treatment)

Type: drug

Status: FDA Approved (for other indications, repurposed for toxoplasmosis)

Developer: GlaxoSmithKline

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026